These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36177003)

  • 1. Novel macrophage-related gene prognostic index for glioblastoma associated with M2 macrophages and T cell dysfunction.
    Ji H; Liu Z; Wang F; Sun H; Wang N; Liu Y; Hu S; You C
    Front Immunol; 2022; 13():941556. PubMed ID: 36177003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Metabolism-Related Gene Prognostic Index Bridging Metabolic Signatures and Antitumor Immune Cycling in Head and Neck Squamous Cell Carcinoma.
    Du K; Zou J; Wang B; Liu C; Khan M; Xie T; Huang X; Shen P; Tian Y; Yuan Y
    Front Immunol; 2022; 13():857934. PubMed ID: 35844514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the prognostic value of HK3 and its association with immune infiltration in glioblastoma multiforme.
    Yang Y; Fu X; Liu R; Yan L; Yang Y
    Front Genet; 2022; 13():1033572. PubMed ID: 36712881
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value and immune relevancy of a combined autophagy-, apoptosis- and necrosis-related gene signature in glioblastoma.
    Bi Y; Wu ZH; Cao F
    BMC Cancer; 2022 Mar; 22(1):233. PubMed ID: 35241019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty Acid Metabolic Signaling Pathway Alternation Predict Prognosis of Immune Checkpoint Inhibitors in Glioblastoma.
    Liu R; Liang W; Hua Q; Wu L; Wang X; Li Q; Zhong F; Li B; Qiu Z
    Front Immunol; 2022; 13():819515. PubMed ID: 35251000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
    Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
    Front Immunol; 2022; 13():950213. PubMed ID: 36072582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of an Immune-Related Prognostic Risk Model in Glioblastoma.
    Lin Z; Wang R; Huang C; He H; Ouyang C; Li H; Zhong Z; Guo J; Chen X; Yang C; Yang X
    Front Genet; 2022; 13():926122. PubMed ID: 35783263
    [No Abstract]   [Full Text] [Related]  

  • 8. A Novel Metabolism-Related Gene Signature for Predicting the Prognosis of HBV-Infected Hepatocellular Carcinoma.
    Gao Z; Chen J; Zhou Y; Deng P; Sun L; Qi J; Zhang P
    J Oncol; 2022; 2022():2391265. PubMed ID: 36072970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic-Related Gene Prognostic Index for Predicting Prognosis, Immunotherapy Response, and Candidate Drugs in Ovarian Cancer.
    Guo S; Liu Y; Sun Y; Zhou H; Gao Y; Wang P; Zhi H; Zhang Y; Gan J; Ning S
    J Chem Inf Model; 2024 Feb; 64(3):1066-1080. PubMed ID: 38238993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Immune-Related Genes Contributing to the Development of Glioblastoma Using Weighted Gene Co-expression Network Analysis.
    Kong Y; Feng ZC; Zhang YL; Liu XF; Ma Y; Zhao ZM; Huang B; Chen AJ; Zhang D; Thorsen F; Wang J; Yang N; Li XG
    Front Immunol; 2020; 11():1281. PubMed ID: 32765489
    [No Abstract]   [Full Text] [Related]  

  • 11. The N
    Zhao R; Li B; Zhang S; He Z; Pan Z; Guo Q; Qiu W; Qi Y; Zhao S; Wang S; Chen Z; Zhang P; Guo X; Xue H; Li G
    Front Immunol; 2021; 12():653711. PubMed ID: 34354698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic identification, development, and validation of prognostic biomarkers involving the tumor-immune microenvironment for glioblastoma.
    Zhao B; Wang Y; Wang Y; Chen W; Liu PH; Kong Z; Dai C; Wang Y; Ma W
    J Cell Physiol; 2021 Jan; 236(1):507-522. PubMed ID: 32572951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The molecular feature of macrophages in tumor immune microenvironment of glioma patients.
    Zhang H; Luo YB; Wu W; Zhang L; Wang Z; Dai Z; Feng S; Cao H; Cheng Q; Liu Z
    Comput Struct Biotechnol J; 2021; 19():4603-4618. PubMed ID: 34471502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction of Molecular Subtypes and Related Prognostic and Immune Response Models Based on M2 Macrophages in Glioblastoma.
    Xiao K; Zhao S; Yuan J; Pan Y; Song Y; Tang L
    Int J Gen Med; 2022; 15():913-926. PubMed ID: 35115817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma.
    Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H
    Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SAA1 Expression as a Potential Prognostic Marker of the Tumor Microenvironment in Glioblastoma.
    Cao K; Jiang X; Wang B; Ni Z; Chen Y
    Front Neurol; 2022; 13():905561. PubMed ID: 35756918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a key glioblastoma candidate gene, FUBP3, based on weighted gene co-expression network analysis.
    Li J; Zhang Z; Guo K; Wu S; Guo C; Zhang X; Wang Z
    BMC Neurol; 2022 Apr; 22(1):139. PubMed ID: 35413821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Colon Cancer to Immunotherapy.
    Wang Z; Song J; Azami NLB; Sun M
    Front Immunol; 2022; 13():802665. PubMed ID: 35572595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a novel autophagy-related prognostic signature and small molecule drugs for glioblastoma by bioinformatics.
    Wang D; Jiang Y; Wang T; Wang Z; Zou F
    BMC Med Genomics; 2022 May; 15(1):111. PubMed ID: 35550147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment and validation of an immune-based prognostic score model in glioblastoma.
    Qin Z; Zhang X; Chen Z; Liu N
    Int Immunopharmacol; 2020 Aug; 85():106636. PubMed ID: 32534425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.